{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:11Z","timestamp":1791389291645,"version":"4.3.3"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jaip.2022.01.011","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T12:10:59Z","timestamp":1643026259000},"page":"1367-1370.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treatment of STAT3-deficient hyper\u2013immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation"],"prefix":"10.1016","volume":"10","author":[{"given":"Alyssa E.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katheryn","family":"Schloss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Nataraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1t\u00e9","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Raasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Risma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna R.E.","family":"Bergerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hey","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.01.011_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2022.01.011_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.20100799","article-title":"Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells","volume":"208","author":"Saito","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2022.01.011_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jdcr.2021.03.007","article-title":"Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis","volume":"11","author":"Su","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaip.2022.01.011_bib4","doi-asserted-by":"crossref","first-page":"108452","DOI":"10.1016\/j.clim.2020.108452","article-title":"Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome","volume":"215","author":"Sogkas","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2022.01.011_bib5","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.chest.2020.11.042","article-title":"Benralizumab for prednisone-dependent eosinophilic asthma associated with novel STAT3 loss of function mutation","volume":"159","author":"Adatia","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2022.01.011_bib6","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1016\/j.jaip.2021.06.049","article-title":"Treatment of severe atopic dermatitis and eosinophilic esophagitis with dupilumab in a 14-year-old boy with autosomal dominant hyper-IgE syndrome","volume":"9","author":"Dixit","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.01.011_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10875-020-00751-4","article-title":"Efficacy of dupilumab for controlling severe atopic dermatitis in hyper-IgE syndrome","volume":"40","author":"Levy","year":"2020","journal-title":"J\u00a0Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:32:48Z","timestamp":1761975168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2213219822000277"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.01.011","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of STAT3-deficient hyper\u2013immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}